COSM
Cosmos Health Inc.
COSM lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
COSM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Weak |
COSM's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
COSM PE Valuation
COSM has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 2.1x next year's earnings.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
COSM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
COSM has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
COSM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.10 | โ |
| Q2 2026 | -$0.66 | +$0.38 |
| Q1 2026 | -$0.66 | +$0.43 |
| Q4 2025 | -$0.63 | +$0.54 |
| Q3 2025 | -$0.76 | +$1.70 |
| Q2 2025 | -$1.04 | +$1.24 |
| Q1 2025 | -$1.09 | +$1.13 |
| Q4 2024 | -$1.17 | +$0.98 |
| Q3 2021 | -$11.50 | -454% |
COSM has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
COSM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19M | +29% |
| Q1 2026 | $17.9M | +31% |
| Q4 2025 | $19.7M | +39% |
| Q3 2025 | $17.1M | +38% |
| Q2 2025 | $14.7M | +12% |
| Q1 2025 | $13.7M | -6% |
| Q4 2024 | $14.2M | -10% |
| Q3 2024 | $12.4M | -3.2% |
COSM's revenue has grown year over year for five quarters in a row: $19M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -15% | +2.5 points |
| Q1 2026 | -12% | -6.1 points |
| Q4 2025 | -58% | +5.1 points |
| Q3 2025 | -11% | +7.4 points |
| Q2 2025 | -18% | +1 points |
| Q1 2025 | -6.1% | +6.5 points |
| Q4 2024 | -63% | +23 points |
| Q3 2024 | -18% | +5.5 points |
COSM's operating margin was โ15% last quarter, up 2.5 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over COSM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over COSM on profitability, with a higher operating margin.
COSM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | -$549.4K |
| Q1 2026 | -$1.1M | -$879.6K |
| Q4 2025 | -$4.6M | -$697.9K |
| Q3 2025 | -$2.5M | -583% |
| Q2 2025 | -$1.2M | +$12.6K |
| Q1 2025 | -$198.8K | +$3.3M |
| Q4 2024 | -$3.9M | -532% |
| Q3 2024 | $511K | +$5.1M |
COSM has burned cash in almost every quarter: โ$10M over the past year, against โ$5M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over COSM on cash generation, producing positive trailing cash flow while its opponent burns cash.
COSM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | 8.5x | High |
| Q4 2020 | 3.3x | Elevated |
| Q3 2020 | -0.3x | Net Cash |
| Q2 2020 | -1.1x | Net Cash |
| Q1 2020 | -1.9x | Net Cash |
| Q4 2019 | 0.6x | Very low |
COSM's net debt is about 8.5 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
COSM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 31.7 | Neutral |
COSM's weekly RSI is 41 (neutral) and its Stochastic is 32 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
COSM PE vs Healthcare Sector
| Metric | COSM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
COSM has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
HIMS has no meaningful PE right now: it lost money over the past year.
COSM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.31 | 32% below |
| 20 week MA | $0.27 | 22% below |
| 50 week MA | $0.33 | 36% below |
| 100 week MA | $0.49 | 57% below |
| 200 week MA | $1.10 | 81% below |
COSM is in a downtrend: it's below all five of its weekly moving averages, and 81% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
COSM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $62.5 | $127.5 | +104% |
| 2021 | $127.5 | $99.0 | -22% |
| 2022 | $99.0 | $6.40 | -94% |
| 2023 | $6.40 | $1.41 | -78% |
| 2024 | $1.41 | $0.68 | -52% |
| 2025 | $0.68 | $0.51 | -25% |
| 2026 YTD | $0.51 | $0.21 | -59% |
COSM has finished five years in a row lower, and it's down 59% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over COSM on returns for 2026, with the stronger performance.